Skip to main content
Equibles

FMR LLC

Position in FTRE — Fortrea Holdings Inc.

CIK 315066 BOSTON, MA
Back to FTRE Full portfolio

Position in FTRE

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$63,456,599
+$51,736,830 QoQ
Shares Held
3,646,931
+193.1% QoQ
Ownership
3.83%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 334 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FTRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,908,415,112 across 370 Biotechnology names. FTRE ranks #112 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 5,231,452 $4,853,584,218
2 ALNY
Alnylam Pharmaceuticals, Inc.
 15,023,962 $4,522,663,276
3 MRNA
Moderna, Inc.
 51,859,891 $3,631,748,165
4 ROIV
Roivant Sciences Ltd.
 81,020,390 $2,867,311,601
5 RVMD
Revolution Medicines, Inc.
 12,200,422 $2,284,895,029
6 IONS
Ionis Pharmaceuticals Inc
 24,631,956 $1,953,067,789
7 INSM
INSMED Inc
 16,143,583 $1,721,228,815
8 KRYS
Krystal Biotech, Inc.
 4,418,197 $1,642,111,277

All Filings in FTRE

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $63,456,599 3,646,931
2026-03-31 $11,719,769 1,244,137
2025-12-31 $45,542,690 2,640,156
2025-09-30 $25,701,931 3,052,486
2025-06-30 $15,171,148 3,071,083
2025-03-31 $39,657,432 5,252,640
2024-12-31 $150,818,930 8,086,806
2024-09-30 $96,428,080 4,821,404
2024-06-30 $58,740,406 2,516,727
2024-03-31 $38,127,218 949,856
2023-12-31 $8,592,344 246,199
2023-09-30 $30,122,508 1,053,603